Scale for the Assessment of Negative Symptoms structure in first episode psychosis

Psychiatry Research

Volumn 210, Issue 3, 2013, Pages 1191-1197

  Lyne, John ^a,b   Renwick, Laoise ^a,b   Grant, Tim ^b   Kinsella, Anthony ^a   McCarthy, Patricia ^c   Malone, Kevin ^c   Turner, Niall ^a   O'Callaghan, Eadbhard ^a,b,d   Clarke, Mary ^a,b,d  

^a DETECT   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^d St John of God Hospitaller Services Ireland   (Ireland)

Author keywords

Diagnosis; Experiential; Expressivity; First episode psychosis

Indexed keywords

NEUROLEPTIC AGENT;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; AWARENESS; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE DURATION; DSM-IV; EMPLOYMENT; FACTORIAL ANALYSIS; FEMALE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MONTE CARLO METHOD; ONSET AGE; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PSYCHOSIS; RATING SCALE; SCALE FOR THE ASSESSMENT OF NEGATIVE SYMPTOMS; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; SENSITIVITY AND SPECIFICITY; SYMPTOMATOLOGY; CLASSIFICATION; FOLLOW UP; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; PSYCHOMETRY; PSYCHOTIC DISORDERS; QUESTIONNAIRE; SCHIZOPHRENIA, PARANOID; SYMPTOM ASSESSMENT;

ADULT; FACTOR ANALYSIS, STATISTICAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PRINCIPAL COMPONENT ANALYSIS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; PSYCHOTIC DISORDERS; QUESTIONNAIRES; SCHIZOPHRENIA; SCHIZOPHRENIA, PARANOID; SCHIZOPHRENIC PSYCHOLOGY; SYMPTOM ASSESSMENT;

EID: 84888293032     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2013.09.008     Document Type: Article

References (84)

1. Addington D., Addington J., Maticka-Tyndale E. Assessing depression in schizophrenia: the Calgary Depression scale. British Journal of Psychiatry 1993, 39-44. (Supplement).
2. Akaike H. A new look at the statistical model identification. IEEE Transactions on Automatic Control 1974, 19:716-723.
3. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2000, American Psychiatric Association, Arlington, VA. 4th ed.
4. American Psychiatric Association Handbook of Psychiatric Measures 2000, American Psychiatric Association, Washington DC.
5. Andreasen N.C. Thought, language, and communication disorders. II. Diagnostic significance. Archives of General Psychiatry 1979, 36:1325-1330.
6. Andreasen N.C. Negative symptoms in schizophrenia. Definition and reliability. Archives of General Psychiatry 1982, 39:784-788.
7. Andreasen N.C. The Scale for the Assessment of Negative Symptoms (SANS) 1984, University of Iowa, Iowa City, Iowa.
8. Andreasen N.C. The Scale for the Assessment of Positive Symptoms (SAPS) 1984, University of Iowa, Iowa City, Iowa.
9. Andreasen N.C. The scale for the assessment of negative symptoms (SANS): conceptual and theoretical foundations. British Journal of Psychiatry 1989, 49-58. (Supplement).
10. Andreasen N.C. Methods for assessing positive and negative symptoms. Modern Problems of Pharmacopsychiatry 1990, 24:73-88.
11. Andreasen N.C., Arndt S., Alliger R., Miller D., Flaum M. Symptoms of schizophrenia. Methods, meanings, and mechanisms. Archives of General Psychiatry 1995, 52:341-351.
12. Andreasen N.C., Flaum M., Swayze V.W., Tyrrell G., Arndt S. Positive and negative symptoms in schizophrenia. A critical reappraisal. Archives of General Psychiatry 1990, 47:615-621.
13. Arrindell W., van der Ende J. An empirical test of the utility of the observations-to-variables ratio in factor and components analysis. Applied Psychological Measurement 1985, 9:165-178.
14. Barnes T.R., Leeson V.C., Mutsatsa S.H., Watt H.C., Hutton S.B., Joyce E.M. Duration of untreated psychosis and social function: 1-year follow-up study of first-episode schizophrenia. British Journal of Psychiatry 2008, 193:203-209.
15. Beiser M., Erickson D., Fleming J.A., Iacono W.G. Establishing the onset of psychotic illness. American Journal of Psychiatry 1993, 150:1349-1354.
16. Bentler P.M. Comparative fit indexes in structural models. Psychological Bulletin 1990, 107:238-246.
17. Blanchard J.J., Cohen A.S. The structure of negative symptoms within schizophrenia: implications for assessment. Schizophrenia Bulletin 2006, 32:238-245.
18. Blanchard J.J., Horan W.P., Collins L.M. Examining the latent structure of negative symptoms: is there a distinct subtype of negative symptom schizophrenia?. Schizophrenia Research 2005, 77:151-165.
19. Blanchard J.J., Kring A.M., Horan W.P., Gur R. Toward the next generation of negative symptom assessments: the collaboration to advance negative symptom assessment in schizophrenia. Schizophrenia Bulletin 2011, 37:291-299.
20. Bleuler E. Dementia Praecox or the Group of Schizophrenias 1950, International Universities Press, New York, NY.
21. Bryant F.B., Yarnold P.R. Principal components analysis and exploratory and confirmatory factor analysis. Reading and Understanding Multivariate Statistics 1995, 99-136. American Psychological Association, Washington, DC. L.G. Grimm, R.R. Yarnold (Eds.).
22. Buchanan R.W. Persistent negative symptoms in schizophrenia: an overview. Schizophrenia Bulletin 2007, 33:1013-1022.
23. Cannon-Spoor H.E., Potkin S.G., Wyatt R.J. Measurement of premorbid adjustment in chronic schizophrenia. Schizophrenia Bulletin 1982, 8:470-484.
24. Crow T.J. The two-syndrome concept: origins and current status. Schizophrenia Bulletin 1985, 11:471-486.
25. Demjaha A., Morgan K., Morgan C., Landau S., Dean K., Reichenberg A., Sham P., Fearon P., Hutchinson G., Jones P.B., Murray R.M., Dazzan P. Combining dimensional and categorical representation of psychosis: the way forward for DSM-V and ICD-11?. Psychological Medicine 2009, 39:1943-1955.
26. Dollfus S., Petit M. Principal-component analyses of PANSS and SANS-SAPS in schizophrenia: their stability in an acute phase. European Psychiatry 1995, 10:97-106.
27. Edwards J., McGorry P.D., Waddell F.M., Harrigan S.M. Enduring negative symptoms in first-episode psychosis: comparison of six methods using follow-up data. Schizophrenia Research 1999, 40:147-158.
28. Fabrigar L., Wegener D., MacCallum R., Strahan E. Evaluating the use of exploratory factor analysis in psychological research. Psychological Methods 1999, 4:272-299.
29. Fennig S., Bromet E.J., Galambos N., Putnam K. Diagnosis and six-month stability of negative symptoms in psychotic disorders. European Archives of Psychiatry and Clinical Neuroscience 1996, 246:63-70.
30. First M.B., Spitzer R.L., Gibbon M., Williams J.B. Structured Clinical Interview for DSM-IV Axis I Disorders 1995, New York:Biometrics Research, State Psychiatric Institute, New York.
31. Galderisi S., Bucci P., Mucci A., Kirkpatrick B., Pini S., Rossi A., Vita A., Maj M. Categorical and dimensional approaches to negative symptoms of schizophrenia: focus on long-term stability and functional outcome. Schizophrenia Research 2013, 147:157-162.
32. Galderisi S., Maj M. Deficit schizophrenia: an overview of clinical, biological and treatment aspects. European Psychiatry. 2009, 24:493-500.
33. Gorsuch R.L. Factor Analysis 1983, Erlbaum, Hillsdale, NJ. 2nd ed.
34. Hair J., Anderson R., Tatham W., Black W. Multivariate Data Analysis 1998, Prentice Hall International, London. 5th ed.
35. Hegelstad W.T., Larsen T.K., Auestad B., Evensen J., Haahr U., Joa I., Johannesen J.O., Langeveld J., Melle I., Opjordsmoen S., Rossberg J.I., Rund B.R., Simonsen E., Sundet K., Vaglum P., Friis S., McGlashan T. Long-term follow-up of the TIPS early detection in psychosis study: effects on 10-year outcome. American Journal of Psychiatry 2012, 169:374-380.
36. Henry L.P., Amminger G.P., Harris M.G., Yuen H.P., Harrigan S.M., Prosser A.L., Schwartz O.S., Farrelly S.E., Herrman H., Jackson H.J., McGorry P.D. The EPPIC follow-up study of first-episode psychosis: longer-term clinical and functional outcome 7 years after index admission. Journal of Clinical Psychiatry 2010, 71:716-728.
37. Herbener E.S., Harrow M. Longitudinal assessment of negative symptoms in schizophrenia/schizoaffective patients, other psychotic patients, and depressed patients. Schizophrenia Bulletin 2001, 27:527-537.
38. Horan W.P., Kring A.M., Gur R.E., Reise S.P., Blanchard J.J. Development and psychometric validation of the clinical assessment interview for negative symptoms (CAINS). Schizophrenia Research 2011, 132:140-145.
39. Hu L., Bentler P.M. Cutoff criteria for fit index in covariance structure analysis: conventional criteria versus new alternatives. Structural Equation Modeling 1999, 6:1-55.
40. Kamphuis J.H., Noordhof A. On categorical diagnoses in DSM-V: cutting dimensions at useful points?. Psychological Assessment 2009, 21:294-301.
41. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 1987, 13:261-276.
42. Keefe R.S., Harvey P.D., Lenzenweger M.F., Davidson M., Apter S.H., Schmeidler J., Mohs R.C., Davis K.L. Empirical assessment of the factorial structure of clinical symptoms in schizophrenia: negative symptoms. Psychiatry Research 1992, 44:153-165.
43. Kelley M.E., van Kammen D.P., Allen D.N. Empirical validation of primary negative symptoms: independence from effects of medication and psychosis. American Journal of Psychiatry 1999, 156:406-411.
44. Kimhy D., Yale S., Goetz R.R., McFarr L.M., Malaspina D. The factorial structure of the schedule for the deficit syndrome in schizophrenia. Schizophrenia Bulletin 2006, 32:274-278.
45. Kirkpatrick B., Buchanan R.W., Ross D.E., Carpenter W.T. A separate disease within the syndrome of schizophrenia. Archives of General Psychiatry 2001, 58:165-171.
46. Kirkpatrick B., Fenton W.S., Carpenter W.T., Marder S.R. The NIMH-MATRICS consensus statement on negative symptoms. Schizophrenia Bulletin 2006, 32:214-219.
47. Kirkpatrick B., Galderisi S. Deficit schizophrenia: an update. World Psychiatry 2008, 7:143-147.
48. Kirkpatrick B., Strauss G.P., Nguyen L., Fischer B.A., Daniel D.G., Cienfuegos A., Marder S.R. The brief negative symptom scale: psychometric properties. Schizophrenia Bulletin 2011, 37:300-305.
49. Kitamura T., Okazaki Y., Fujinawa A., Yoshino M., Kasahara Y. Symptoms of psychoses. A factor-analytic study. British Journal of Psychiatry 1995, 166:236-240.
50. Kline P. Handbook of Psychological Testing 2000, Routledge, London. 2nd ed.
51. Kring A.M., Gur R.E., Blanchard J.J., Horan W.P., Reise S.P. The clinical assessment interview for negative symptoms (CAINS): final development and validation. American Journal of Psychiatry 2013, 170:165-172.
52. Landis J.R., Koch G.G. The measurement of observer agreement for categorical data. Biometrics 1977, 33:159-174.
53. Levine S.Z., Leucht S. Psychometric analysis in support of shortening the Scale for the Assessment of Negative Symptoms. European Neuropsychopharmacology 2013, 23:1051-1056.
54. Liemburg E., Castelein S., Stewart R., van der Gaag M., Aleman A., Knegtering H. Two subdomains of negative symptoms in psychotic disorders: Established and confirmed in two large cohorts. Journal of Psychiatric Research 2013, 47:718-725.
55. Lyne J., O'Donoghue B., Owens E., Renwick L., Madigan K., Kinsella A., Clarke M., Turner N., O'Callaghan E. Prevalence of item level negative symptoms in first episode psychosis diagnoses. Schizophrenia Reseach 2012, 135:128-133.
56. Lyne, J., Renwick, L., Madigan, K., O'Donoghue, B., Bonar, M., Grant, T., Kinsella, A., Malone, K., Turner, N., O'Callaghan, E., Clarke, M., 2013. Do psychosis prodrome onset negative symptoms predict first presentation negative symptoms? European Psychiatry. http://dx.doi.org/10.1016/j.eurpsy.2013.02.003.
57. MacCallum R., Widaman K., Zhang S., Hong S. Sample size in factor analysis. Psychological Methods 1999, 4:84-99.
58. Malla A.K., Takhar J.J., Norman R.M., Manchanda R., Cortese L., Haricharan R., Verdi M., Ahmed R. Negative symptoms in first episode non-affective psychosis. Acta Psychiatrica Scandinavica 2002, 105:431-439.
59. McGlashan T.H., Fenton W.S. The positive-negative distinction in schizophrenia. Review of natural history validators. Archives of General Psychiatry 1992, 49:63-72.
60. McGorry P.D., Bell R.C., Dudgeon P.L., Jackson H.J. The dimensional structure of first episode psychosis: an exploratory factor analysis. Psychological Medicine 1998, 28:935-947.
61. Messinger J.W., Tremeau F., Antonius D., Mendelsohn E., Prudent V., Stanford A.D., Malaspina D. Avolition and expressive deficits capture negative symptom phenomenology: implications for DSM-5 and schizophrenia research. Clinical Psychology Review 2011, 31:161-168.
62. Milev P., Ho B.C., Arndt S., Andreasen N.C. Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. American Journal of Psychiatry 2005, 162:495-506.
63. Mueser K.T., Sayers S.L., Schooler N.R., Mance R.M., Haas G.L. A multisite investigation of the reliability of the scale for the assessment of negative symptoms. American Journal of Psychiatry 1994, 151:1453-1462.
64. Palacios-Araus L., Herran A., Sandoya M., Gonzalez de la H.E., Vazquez-Barquero J.L., ez-Manrique J.F. Analysis of positive and negative symptoms in schizophrenia. A study from a population of long-term outpatients. Acta Psychiatrica Scandinavica 1995, 92:178-182.
65. Peralta V., Cuesta M.J. Negative symptoms in schizophrenia: a confirmatory factor analysis of competing models. American Journal of Psychiatry 1995, 152:1450-1457.
66. Pogue-Geile M.F., Harrow M. Negative and positive symptoms in schizophrenia and depression: a followup. Schizophrenia Bulletin 1984, 10:371-387.
67. Rabany L., Weiser M., Werbeloff N., Levkovitz Y. Assessment of negative symptoms and depression in schizophrenia: revision of the SANS and how it relates to the PANSS and CDSS. Schizophrenia Research 2011, 126:226-230.
68. Regier D.A., Narrow W.E., Kuhl E.A., Kupfer D.J. The conceptual development of DSM-V. American Journal of Psychiatry 2009, 166:645-650.
69. Rey E.R., Bailer J., Brauer W., Handel M., Laubenstein D., Stein A. Stability trends and longitudinal correlations of negative and positive syndromes within a three-year follow-up of initially hospitalized schizophrenics. Acta Psychiatrica Scandinavica 1994, 90:405-412.
70. Rosenman S., Korten A., Medway J., Evans M. Dimensional vs. categorical diagnosis in psychosis. Acta Psychiatrica Scandinavica 2003, 107:378-384.
71. Salokangas R.K. Structure of schizophrenic symptomatology and its changes over time: prospective factor-analytical study. Acta Psychiatrica Scandinavica 1997, 95:32-39.
72. Sapnas K.G., Zeller R.A. Minimizing sample size when using exploratory factor analysis for measurement. Journal of Nursing Measurement 2002, 10:135-154.
73. Sayers S.L., Curran P.J., Mueser K.T. Factor structure and construct validity of the scale for the assessment of negative symptoms. Psychological Assessment. 1996, 8:269-280.
74. Schneider M., Van der Linden M., Glaser B., Rizzi E., Dahoun S.P., Hinard C., Bartoloni L., Antonarakis S.E., Debbane M., Eliez S. Preliminary structure and predictive value of attenuated negative symptoms in 22q11.2 deletion syndrome. Psychiatry Research 2012, 196:277-284.
75. Serretti A., Olgiati P. Dimensions of major psychoses: a confirmatory factor analysis of six competing models. Psychiatry Research 2004, 127:101-109.
76. Strauss G.P., Hong L.E., Gold J.M., Buchanan R.W., McMahon R.P., Keller W.R., Fischer B.A., Catalano L.T., Culbreth A.J., Carpenter W.T., Kirkpatrick B. Factor structure of the brief negative symptom scale. Schizophrenia Research 2012, 142:96-98.
77. Strauss G.P., Horan W.P., Kirkpatrick B., Fischer B.A., Keller W.R., Miski P., Buchanan R.W., Green M.F., Carpenter W.T. Deconstructing negative symptoms of schizophrenia: avolition-apathy and diminished expression clusters predict clinical presentation and functional outcome. Journal of Psychiatric Research 2013, 47:783-790.
78. Suhr, D., 2006. Exploratory or confirmatory factor analysis? In: Proceedings of the Thirty-First Annual SAS Users Group International Conference. SAS Institute, Cary, NC. Paper 200-31.
79. Tandon R., DeQuardo J.R., Taylor S.F., McGrath M., Jibson M., Eiser A., Goldman M. Phasic and enduring negative symptoms in schizophrenia: biological markers and relationship to outcome. Schizophrenia Research 2000, 45:191-201.
80. Tandon R., Nasrallah H.A., Keshavan M.S. Schizophrenia, "just the facts" 4. Clinical features and conceptualization. Schizophrenia Research 2009, 110:1-23.
81. Toomey R., Faraone S.V., Simpson J.C., Tsuang M.T. Negative, positive, and disorganized symptom dimensions in schizophrenia, major depression, and bipolar disorder. Journal of Nervous and Mental Disease 1998, 186:470-476.
82. van der Gaag M., Cuijpers A., Hoffman T., Remijsen M., Hijman R., de Haan L., van Meijel B., van Harten P.N., Valmaggia L., de Hert M., Wiersma D. The five-factor model of the positive and negative syndrome scale I: confirmatory factor analysis fails to confirm 25 published five-factor solutions. Schizophrenia Research 2006, 85:273-279.
83. Velicer W.F., Jackson D.N. Component analysis versus common factor analysis: some issues in selecting an appropriate procedure. Multivariate Behavioral Research 1999, 25:1-28.
84. WHO The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and DIagnostic Guidelines 1992, World Health Organisation, Geneva. 10th ed.